Dr. Greg Cooper talks with Dr. Walter J. Koroshetz about his advice for early neurologists.

Read more about the 2026 AAN President's Award.

Dr. Greg Cooper and Dr. Eric Reiman discuss emerging antibody therapies for preclinical Alzheimer's disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care.

Show citation:

Reiman EM, Alexander RC, Langbaum JB, et al. A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA. Lancet Neurol. 2026;25(3):268-278. doi:10.1016/S1474-4422(25)00483-1

In the first part of this series, Dr. Justin Abbatemarco and Dr. Shreya Louis discuss the background and evolving terminology around circulating tumor DNA, cell‑free DNA and CSF‑based testing in neurology.

Read more about this abstract on the AAN website.

In part two of this series, Dr. Tesha Monteith and Dr. Brett Lauring discuss the clinical trial design, including the objectives and methods.

Read more about this abstract on the AAN website.

In this episode, Dr. Andy Southerland reviews the Capitol Hill Report from April 6th, focusing on news related to appropriations and several new bills.

Stay updated with what's happening on the hill by visiting aan.com/chr.

Learn how you can get involved with AAN advocacy.

Join the conversation by visiting the Letters to the Editor section.

Dr. H.E. Hinson and Dr. Vijay Ramanan discuss the upcoming Clinical Trials Plenary Session at the AAN Annual Meeting and the landmark studies shaping neurological care.

For more information about this event, visit the AAN website.

In part one of this series, Dr. Tesha Monteith and Dr. Brett Lauring discuss the potential role TRPM8 antagonist may play in the management of migraine.

Read more about this abstract on the AAN website.

In part two of this series, Dr. Justin Abbatemarco and Lizzy Lawrence discuss recent FDA guidance, focusing on broader agency changes and how this messaging differs from the FDA's traditional communication around regulatory decision-making.

Show citation:

https://www.statnews.com/2025/12/04/fda-considers-single-clinical-trial-for-new-product-approvals/

In the March episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss some of the most pressing challenges facing academic neurology while supporting neurologists in all practice settings.

Stay informed by watching the President's Spotlight video.